×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KAPA – kairos pharma, ltd. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KAPA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
08:41 am
kapa
Kairos Pharma Approved to Dual List on Upstream [Yahoo! Finance]
Medium
Report
Kairos Pharma Approved to Dual List on Upstream [Yahoo! Finance]
11/19
08:30 am
kapa
Kairos Pharma Approved to Dual List on Upstream
Medium
Report
Kairos Pharma Approved to Dual List on Upstream
10/22
09:00 am
kapa
Kairos Pharma to Present at the LD Micro Main Event XVII
Medium
Report
Kairos Pharma to Present at the LD Micro Main Event XVII
10/9
04:30 pm
kapa
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Low
Report
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
9/24
04:26 pm
kapa
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients [Yahoo! Finance]
High
Report
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients [Yahoo! Finance]
9/24
04:20 pm
kapa
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
Medium
Report
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
9/17
04:29 pm
kapa
Kairos Pharma Closing of $6.2 Million Initial Public Offering
Medium
Report
Kairos Pharma Closing of $6.2 Million Initial Public Offering
9/16
10:58 am
kapa
Kairos Pharma Prices $6.2 Million Initial Public Offering [Yahoo! Finance]
High
Report
Kairos Pharma Prices $6.2 Million Initial Public Offering [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
09:54 pm
kapa
Form 4 Kairos Pharma, LTD. For: Nov 20 Filed by: Yu John S
Neutral
Report
Form 4 Kairos Pharma, LTD. For: Nov 20 Filed by: Yu John S
11/19
08:49 am
kapa
Form 8-K Kairos Pharma, LTD. For: Nov 19
Medium
Report
Form 8-K Kairos Pharma, LTD. For: Nov 19
11/14
02:19 pm
kapa
Form 10-Q Kairos Pharma, LTD. For: Sep 30
Medium
Report
Form 10-Q Kairos Pharma, LTD. For: Sep 30
10/10
05:31 pm
kapa
Form 8-K Kairos Pharma, LTD. For: Oct 09
Medium
Report
Form 8-K Kairos Pharma, LTD. For: Oct 09
10/4
05:30 pm
kapa
Form 8-K Kairos Pharma, LTD. For: Oct 01
Medium
Report
Form 8-K Kairos Pharma, LTD. For: Oct 01
9/27
05:11 pm
kapa
Form 8-K Kairos Pharma, LTD. For: Sep 23
Low
Report
Form 8-K Kairos Pharma, LTD. For: Sep 23
9/24
09:01 pm
kapa
Form 3 Kairos Pharma, LTD. For: Sep 16 Filed by: Yu John S
High
Report
Form 3 Kairos Pharma, LTD. For: Sep 16 Filed by: Yu John S
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: